等待開盤 05-30 09:30:00 美东时间
-2.320
-1.26%
Piper Sandler analyst Alexander Goldfarb maintains AvalonBay Communities (NYSE:AVB) with a Neutral and raises the price target from $183 to $195.
05-29 19:35
Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed transactions may contain terms that could limit superior competing offers. S...
05-26 03:16
AvalonBay (AVB) and Equity Residential (EQR) agree to merge in a $52B deal, creating a 180,000-unit apartment REIT with strong synergies.
05-22 02:20
https://www.bloomberg.com/news/articles/2026-05-20/avalonbay-equity-residential-said-to-near-mega-reit-tie-up
05-21 15:50
今日重点评级关注:HC Wainwright & Co.:维持Autolus Therapeutics"买入"评级,目标价从9美元升至10美元;Maxim Group:维持Rezolute"买入"评级,目标价从4美元升至10美元
05-15 10:49
Scotiabank analyst Nicholas Yulico maintains AvalonBay Communities (NYSE:AVB) with a Sector Perform and lowers the price target from $190 to $187.
05-14 21:05
今日重点评级关注:HC Wainwright & Co.:维持Caribou Biosciences"买入"评级,目标价从9美元升至11美元;康托·菲茨杰拉德:维持Artiva Biotherapeutics"超配"评级,目标价从10美元升至40美元
05-12 12:36
今日重点评级关注:Canaccord Genuity:维持Sagimet Biosciences"买入"评级,目标价从28美元升至49美元;HC Wainwright & Co.:维持Fate Therapeutics"买入"评级,目标价从5美元升至7美元
05-05 11:40
Cantor Fitzgerald analyst Richard Anderson maintains AvalonBay Communities (NYSE:AVB) with a Neutral and raises the price target from $186 to $190.
05-04 21:34
今日重点评级关注:HC Wainwright & Co.:维持Protara Therapeutics"买入"评级,目标价从23美元升至27美元;BTIG:维持Black Diamond Therapeutic"买入"评级,目标价从10美元升至11美元
04-30 19:24